
- Pharmaceutical Technology's In the Lab eNewsletter, December 2021
- Volume 16
- Issue 12
New Carbon Nanotube-Based Sensor Can Detect SARS-CoV-2 Proteins
Researchers from MIT have developed novel nanosensors for the detection of the nucleocapsid and spike protein of the SARS-CoV-2 virus.
Researchers from the Massachusetts Institute of Technology (MIT) announced the development of novel nanosensors for the detection of nucleocapsid and spike protein of the SARS-CoV-2 virus in a Nov. 10, 2021 press release. The Corona Phase Molecular Recognition (CoPhMoRe) sensors were born out of a collaboration between MIT and InnoTech Precision Medicine, an early-stage diagnostics company. and developed within a short timeframe of 10 days.
According to research findings published in Analytical Chemistry in October 2021 (1), researchers used single-walled carbon nanotubes and polymers to develop the CoPhMoRe sensors. These sensors aim to provide a platform for quick development of fast and accurate diagnostic, monitoring, and surveillance tests for detection of current and emergent pathogens.
“New technologies using innovative material and strategies are key for quick and efficient diagnosis and disease control.” said Roya Khosravi-Far, CEO and co-founder of InnoTech, in the press release. “Conventional diagnostics are expensive, specialized, and slow to develop; we need to modernize our diagnostic tests to drive robust public health response to existing and emerging threats.”
Reference
1. Cho Soo-Yeon, et al. Anal Chem. online, 93 (44) (Nov. 9, 2021)
Source: InnoTech Precision Medicine
Articles in this issue
almost 4 years ago
Contamination Control for Cell and Gene Therapies Needs New Analyticsalmost 4 years ago
MilliporeSigma Unveils ColorWheel Flow Cytometry Portfolioalmost 4 years ago
Lonza Invests in Microbial Development Lab Expansionalmost 4 years ago
Synthace Raises $35 Million to Expand Access to R&D Technologyalmost 4 years ago
Fujifilm Irvine Scientific Expands Cell Culture R&D Centeralmost 4 years ago
Element Acquires JMI Laboratoriesalmost 4 years ago
GenScript Opens New Gene Synthesis Center in New Jerseyalmost 4 years ago
Gentronix Expands Lab Facilities, Increases Testing CapacityNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





